eLife (Feb 2018)

Architecture of the human mTORC2 core complex

  • Edward Stuttfeld,
  • Christopher HS Aylett,
  • Stefan Imseng,
  • Daniel Boehringer,
  • Alain Scaiola,
  • Evelyn Sauer,
  • Michael N Hall,
  • Timm Maier,
  • Nenad Ban

DOI
https://doi.org/10.7554/eLife.33101
Journal volume & issue
Vol. 7

Abstract

Read online

The mammalian target of rapamycin (mTOR) is a key protein kinase controlling cellular metabolism and growth. It is part of the two structurally and functionally distinct multiprotein complexes mTORC1 and mTORC2. Dysregulation of mTOR occurs in diabetes, cancer and neurological disease. We report the architecture of human mTORC2 at intermediate resolution, revealing a conserved binding site for accessory proteins on mTOR and explaining the structural basis for the rapamycin insensitivity of the complex.

Keywords